Fetal Growth Restriction: An Update on Recent Trends in Management
Journal Title: Pan Asian Journal of Obstetrics & Gynecology - Year 2018, Vol 1, Issue 1
Abstract
Fetal growth restriction (FGR) denotes a pathological process in which a fetus does not attain its biologically determined growth potential. It is an important cause of perinatal mortality and morbidity. Till date there is lack of consensus on the definition and management of FGR amongst different obstetrical bodies.This review aims to explore the available literature on the subject in order to help in defining FGR and discuss the latest management protocols
Authors and Affiliations
Ayesha Ahmad
Female Genital Tuberculosis Diagnosis to Treatment
Genital tuberculosis in females (FGTB) is a significant cause of morbidity. Mycobacterium tuberculosis is a causative agent for tuberculosis (TB). In majority of cases tubes are involved in almost 90-100% of cases. Endom...
Bladder Pain Syndrome—Current Concepts and Management Guidelines
Interstitial cystitis/Bladder Pain Syndrome (IC/BPS) is a chronic debilitating condition with increasing incidence globally. Despite of regular update of guidelines by different regulatory bodies still there is a lack of...
Type-2 Mayer-Rokitansky-Kuster-Hauser Syndrome with Periureteric Fibrosis: A Rare Association
Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome, Type 2 is a form of mullerian agenesis typically associated with renal, skeletal, and ovarian abnormalities. It has an incidence of 1 in 1,00,000 in general population. Thi...
Luteal Phase Support: Why, When and How
Luteal phase support (LPS) is a known intervention for preventing the pregnancy loss. It is most commonly used in the artificial reproduction cycles. Most common agent used for the LPS is progesterone. Current review dis...
Pigmentation after Iron Polymaltose Infusion: Learning Points
A 40 year multiparous female presented with menorrhagia and severe anemia. She had been diagnosed as a case of fibroid uterus with menorrhagia with iron deficiency anemia. She received 1000 mg of iron polymaltose complex...